In 2014, Kazakhstan must produce 50 percent of medicines consumed in the country, CaspioNet reported. This objective is part of the accelerated industrial and innovative development programme for pharmaceutical and medical industries. By this time, the pharmaceutical enterprises of the country should introduce international standards or GMP. The Almaty pharmaceutical factory, a member of the Turkish pharmaceutical holding, was the first to receive such a certificate. Since 2002, the Almaty plant was modernized and completely reequipped. Now, it produces more than one hundred kinds of medicines, and by 2015 this figure is to increase to 150.
Selcuk Tanriverdi, General Director, NOBEL AFF JSC:
- To do this, we need to work not only as a team but also individually. The head of state gave us a tangible instruction saying that by 2014, we need to increase the volume of Kazakhstan-made medicines to 50%. Today, this share is slightly over 15%, which is why, we now have some time ahead of us and we have some big objectives in order to reach this level.
The plant exports a third of its products to Uzbekistan, Kyrgyzstan, and Turkmenistan. Next year, the company is planning to enter the markets of Russia, Belarus, and Turkey.
Kazakhstan to increase the share of locally produced medicine
In 2014, Kazakhstan must produce 50 percent of medicines consumed in the country.
